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Background: Hip and knee arthroplasty aims to restore the joint function and to improve health-related
quality of life (HRQoL) in patients with articular damage. It is important to quantify the HRQoL
improvement and when this is achieved. The Oxford knee score and the Oxford hip score were developed
to evaluate patients after knee and hip arthroplasty. We sought to evaluate HRQoL changes in the short
and mid term following either primary or revision hip and knee arthroplasty.
Methods: Prospective cohort study during a 20-month period (August 2013 to March 2015) in a tertiary
referral hospital. Primary arthroplasties secondary to osteoarthritis and any-cause revisions were
included (328, 160 knees, and 88 hips). They were divided into 4 groups: (1) primary knee replacement,
(2) primary hip replacement, (3) revision knee replacement, and (4) revision hip replacement. Oxford
knee and hip scores were obtained prior the surgery and compared with the short- and mid-term
follow-up scores.
Results: Follow-up in the short term and mid term was: 75.6% and 67.4%, respectively. Improvement was
found in both short-term and mid-term follow-up for each group and for the overall group in HRQoL as
measured by the Oxford knee and hip scores (P < .001). The greatest improvement was seen in the short
termwith an increase of 21 points for primary knee arthroplasty; 24 points for primary hip arthroplasty;
22 points for revision knee arthroplasty; and 23 points for revision hip arthroplasty.
Conclusions: Improvement in HRQoL in patients following primary or revision hip or knee arthroplasty is
crucial and can be achieved early after the surgery.
© 2016 The Authors. Published by Elsevier Inc. on behalf of The American Association of Hip and Knee
Surgeons. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
Hip and knee osteoarthritis (OA) are frequent chronic degener-
ative conditions that usually cause pain and physical disability, thus
altering health-related quality of life (HRQoL) [1,2]. Its increasing
prevalence and its growing impact on public health may prove
critical for health systems in the near future [3]. Arthroplasties ared any potential or pertinent
conﬂict with this work. For
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day (2016), http://dx.doi.orgcommon orthopaedic procedures to treat OA that emerged in the
last century as a cost-effective alternative to conservative
management [4-8]. As an elective surgery, it is necessary, however,
to assess, with a quantitative instrument, joint functionality
restoration and improvement in HRQoL, which are the main
patient-related outcomes of interest after an arthroplasty.
Aside from the technical aspects of arthroplasties that have been
the focus of outcome assessment for many years in orthopaedics,
patient-reported outcome measures (PROMs) now play an
increasingly important role in the determinants of clinical success,
these providing valuable information regarding HRQoL and patient
satisfaction after the intervention. HRQoL is, however, only one part
of overall quality of life, which corresponds to the physical,
psychological, and social factors that affect the overall healthciation of Hip and Knee Surgeons. This is an open access article under the CC BY-NC-
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mind that this component can provide information on only one
chapter of a complete quality of life assessment.
Currently, in hip and knee replacement patients, HRQoL is
evaluated through different scores and questionnaires, meaning
that there is a lack of uniformity, which makes it challenging to
understand the diverse literature [9,10]. Most of these tests have
been validated and show proven reproducibility [11-13]; however,
research shows that hip and knee replacement patients prefer
pen-and-paper questionnaires to other types of questionnaires
[14]. The Oxford knee score (OKS) and Oxford hip score (OHS) are
short and practical pen-and-paper tests which were developed to
assess patient perspectives of HRQoL outcomes following a hip or
knee arthroplasty [15,16]. The OKS has also been validated in
outpatients with knee OA [17]. These scores have shown reliability
in different languages [18-21].
Clinical consensus recommends that the optimal time point to
start assessing PROMs is within the ﬁrst 6 months post surgery
[22]; and it is well known that changes in HRQoL could be achieved
at this point and, later, after surgery [22-25]. There is scarce
information of PROMs using OKS and OHS before the ﬁrst 6-month
period. We sought, therefore, to evaluate whether signiﬁcant
improvement could be achieved in an earlier follow-up stage for
overall hip and knee arthroplasties, in the primary and revision
subgroups using OKS and OHS.Material and methods
A prospective cohort study was performed at a tertiary referral
hospital in Cali, Colombia, during a 20-month period between
August 2013 andMarch 2015. Enrolled patients were obtained from
the Hip and Knee Arthroplasty Registry prospective cohort at
Fundacion Valle del Lili. The hospital ethics committee and itsFigure 1. Study population. FVL, Fundacion Valle del Lili Joint Registry; AFNF, acute femoral n
fracture; PKR, primary knee replacement; PHR, primary hip replacement; RKR, revision kn
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Arthroplasty Registry used.
All patients undergoing hip or knee arthroplasty (primary or
revision) in the hospital during the study period were included in
the registry, and in this study. Prior to their arthroplasty, patients
included in the registry were asked to complete the OKS or OHS
questionnaire to assess their levels of pain and disability over the
previous 4 weeks for the speciﬁc symptomatic joint. The OKS and
OHS are 12-item multiple-choice questionnaires, giving a score
from 0 to 4 for each question, thus giving a range that goes from
0 for the worst joint status to 48 for a normal joint. Only patients
with OA were included; other indications of arthroplasty such as
musculoskeletal cancer, acute femoral neck fracture, and peri-
prosthetic fractures were excluded. These groups were excluded
because in these patients, the HRQoL assessment by the OKS or OHS
might be not affected, given their other conditions, leading to an
asymptomatic state for their hip or knee prior to the surgery;
furthermore, the validation of this score in such groups of patient is
unknown.
Enrolled patients were divided into 4 groups regarding the type
of arthroplasty performed: (1) primary knee replacement (PKR);
(2) primary hip replacement (PHR); (3) revision knee replacement
(RKR); and (4) revision hip replacement (RHR). Figure 1 shows the
study population and its distribution. Patients were assessed in 2
periods: the ﬁrst was named the short-term follow-up, which was
deﬁned as the period between 2 and 6 months after the surgery;
and the second was named the mid-term follow-up, which was
deﬁned as the period between 10 and 14 months after the surgery.
During the short-term and mid-term follow-up periods,
patients were asked to complete the OKS/OHS during each visit at
the consulting room. Patients that missed the appointment in this
period of time were called on their contact telephone and were
assessed by phone. Before including a patient in the lost to follow-
up group, at least 5 different attempts of contacting them byeck fracture; PMCM, primary musculoskeletal cancer or metastasis; PPF, periprosthetic
ee replacement; RHR, revision hip replacement.
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Table 1
Patient characteristics.
Hip and knee arthroplasties with complete short-term follow-up
Variable Overall (n ¼ 248) PKR (n ¼ 133) PHR (n ¼ 64) RKR (n ¼ 27) RHR (n ¼ 24)
Age, mean (SD) 66.6 (12.5) 70 (9.0) 63 (14.9) 62.4 (11.9) 63.5 (12.2)
Female, n (%) 174 (70%) 108 (81%) 35 (55%) 15 (56%) 16 (67%)
BMI, mean (SD) 28.2 (4.8) 29 (4.7) 26.1 (4.4) 29.5 (4.6) 26.4 (4.1)
Days to follow-up, mean (SD) 135 (57.3) 135 (62.7) 131.7 (47.3) 137.5 (54.8) 146 (54.2)
Hip and knee arthroplasties with complete mid-term follow-up
Variable Overall (n ¼ 221) PKR (n ¼ 123) PHR (n ¼ 52) RKR (n ¼ 20) RHR (n ¼ 26)
Age, mean (SD) 66.6 (12.7) 70.4 (9.0) 62.5 (15.2) 62.8 (13.0) 60 (15.9)
Female, n (%) 159 (72%) 99 (81%) 32 (62%) 12 (60%) 16 (62%)
BMI, mean (SD) 28 (4.8) 28.9 (4.7) 26.1 (4.6) 29.9 (5.4) 25.9 (3.8)
Days to follow-up, mean (SD) 408.3 (56.6) 400.8 (61.4) 416.2 (47.7) 418.6 (58.8) 419.5 (44.6)
BMI, body mass index; SD, standard deviation; PKR, primary knee replacement; PHR, primary hip replacement; RKR, revision knee replacement; RHR, revision hip
replacement.
J.P. Martinez-Cano et al. / Arthroplasty Today xxx (2016) 1e6 3telephone were made. Any patient who had undergone an
arthroplasty and who then assisted for a limb amputation or revi-
sion of their prosthesis, or who died, was excluded from the follow-
up assessments and was therefore excluded from the statistical
analyses. Furthermore, patients lost to follow-up were also
excluded from the analysis. Demographic and additional study
variables were obtained from the Arthroplasty Registry. The main
study outcome was to compare the initial OKS/OHS with the short-
and mid-term follow-up scores for the overall group and for each
study group.
Descriptive analysis of the variables was performed. Categorical
variables were summarized as absolute frequencies and percent-
ages. Continuous variables were summarized as mean ± standard
deviation or median (interquartile range), and they were compared
using parametric tests (paired t test) or nonparametric tests (Wil-
coxon rank-sum test) according to their distribution. Box plots were
used to display patterns of quantitative data. Values of P < .05
were used to indicate statistical signiﬁcance. All statistical analyses
were performed using STATA 13.0 software.
Results
During the 20-month study period, a total of 386 arthroplasties
were performed at the institution. Of these, 58 arthroplasties metTable 2
Comparisons between presurgery, short-term, and mid-term follow-up in Oxford knee a
Group Presurgery
Median (interquartile range)
Short term
Median (in
Presurgery vs short term
Overall (n ¼ 248) 13 (9-17) 35 (28-41)
PKR (n ¼ 133) 14 (10-17) 35 (29-40)
PHR (n ¼ 64) 13 (9-19) 37 (30-43)
RKR (n ¼ 27) 10 (7-16) 32 (23-36)
RHR (n ¼ 24) 10 (6-18) 33 (26-38)
Presurgery vs mid term
Overall (n ¼ 221) 13 (10-18) d
PKR (n ¼ 123) 14 (11-18) d
PHR (n ¼ 52) 13 (9-20) d
RKR (n ¼ 20) 13 (8-16) d
RHR (n ¼ 26) 12 (6-18) d
Short term vs mid term
Overall (n ¼ 187) d 35 (29-40)
PKR (n ¼ 105) d 35 (30-40)
PHR (n ¼ 45) d 36 (31-42)
RKR (n ¼ 18) d 34 (26-36)
RHR (n ¼ 19) d 34 (25-40)
PKR, primary knee replacement; PHR, primary hip replacement; RKR, revision knee repl
a Wilcoxon rank-sum test.
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musculoskeletal cancer or metastasis, and 1 periprosthetic fracture.
A total of 328 arthroplasties were therefore initially included. For
the short-term analysis, 80 additional patients were excluded from
the analysis because of loss to follow-up (n ¼ 77), prosthesis revi-
sion (n¼ 2), and patient death (n¼ 1), for themid-term analysis, 37
more were excluded from analysis, for loss at follow-up (n¼ 32),
prosthesis revision (n ¼ 3), patient death (n ¼ 2), and limb
amputation (n¼ 1). Finally, 248 arthroplasties were included for the
short-term analysis and 221 for the mid-term follow-up analysis,
giving a 76%/67% response rate for the short-term and mid-term
analyses, respectively. Of the included arthroplasties for the
short-term follow-up analysis, 197 (79%) were primary arthro-
plasties (133 [68%] PKR and 64 [32%] PHR) and 51 (21%) were
revision arthroplasties (27 [53%] RKR and 24 [47%] RHR). For the
mid-term follow-up analysis, 175 (79%) were primary arthro-
plasties (123 [70%] PKR and 52 [30%] PHR) and 46 (21%) were
revision arthroplasties (20 [43%] RKR and 26 (57%) RHR) (Fig. 1).
For all the primary arthroplasties, the only surgical indication
was OA. For hip revision arthoplasty, the principal indication was
loosening (55.6%), followed by infection (25.9%), instability (14.8%),
and arthroﬁbrosis (3.7%); and for knee revision, the ﬁrst cause was
loosening (50.0%), followed by infection (33.5%), instability (8.3%),
osteolysis (4.1%), and polyethylene wear (4.1%). Mean times fornd hip scores (median).
terquartile range)
Mid term
Median (interquartile range)
P valuea
d <.001
d <.001
d <.001
d <.001
d <.001
38 (32-44) <.001
39 (33-43) <.001
42 (36-46) <.001
32 (21-42) <.001
34 (28-44) <.001
39 (32-44) <.001
39 (34-43) <.001
42 (36-45) <.001
32 (20-42) .631
39 (29-45) .135
acement; RHR, revision hip replacement.
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Figure 2. Box-plot diagram comparing presurgery vs short-term Oxford knee score/Oxford hip score follow-up. Box plots show the interquartile range (box), median values
(horizontal line inside the box), 10th/90th percentile values (whiskers), and outlier values (dots). (a) Overall comparison. (b) Subgroup comparisons by type of arthroplasties.
Group 1: PKR, primary knee replacement; group 2: PHR, primary hip replacement; group 3: RKR, revision knee replacement; group 4: RHR, revision hip replacement.
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group and follow-up stage. Table 1 also describes patient charac-
teristics for those patients included in the study for short- and
mid-term follow-up.
The OKS and OHS mean scores for the overall group and
subgroups are shown in Table 2 for the baseline, short-term, and
mid-term stages. Comparisons were made between baseline score
and short-term score, baseline and mid-term scores, and between
short-term andmid-term scores (Figs. 2-4). The OKS and OHSmean
scores changed signiﬁcantly over time. For primary knee arthro-
plasty, the Oxfordmedian score increased by 21 points at the short-
termmeasurement point and by 25 points at mid term. For primary
hip arthroplasty, Oxford median score increased by 24 points at the
short-term measurement point and by 29 points at mid term. For
revision knee arthroplasty, Oxford median score increased by 22
points at the short-term measurement point and by 19 points at
mid term. Finally, for revision hip arthroplasty, Oxford median
score increased by 23 points at the short-term measurement point
and by 22 points at mid term. Comparisons between baseline short-
term and baseline mid-term scores were statistically signiﬁcantFigure 3. Box-plot diagram comparing presurgery vs mid-term Oxford knee score/Oxford
arthroplasties. Group 1: PKR, primary knee replacement; group 2: PHR, primary hip replacem
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(P < .001; Table 2).
These results can be interpreted more easily when they are
normalized to a scale from 0 to 100 and when the short-term and
mid-term measurement points are expressed in mean time in
months. When comparing patients, the baseline results may
change between comparisons, according to the participants
included in the analysis. The results are as follows: Overall group: from baseline (27.1%) to 4.5 months (72.9%) and
from baseline (27.1%) to 13.6 months (79.2%).
 PKR: from baseline (29.2%) to 4.5 months (72.9%) and from
baseline (29.2%) to 13.4 months (81.2%).
 PHR: from baseline (27.1%) to 4.4 months (77.1%) and from
baseline (27.1%) to 13.9 months (87.5%).
 RKR: from baseline (20.8%) to 4.6 months (66.7%) and from
baseline (27.1%) to 14.0 months (66.7%).
 RHR: from baseline (20.8%) to 4.9 months (68.8%) and from
baseline (25.0%) to 14.0 months (70.8%).hip score follow-up. (a) Overall comparison. (b) Subgroup comparisons by type of
ent; group 3: RKR, revision knee replacement; group 4: RHR, revision hip replacement.
uality of life assessment after hip and knee arthroplasty: short- and
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Figure 4. Box-plot diagram comparing short-term vs mid-term Oxford knee score/Oxford hip score follow-up. (a) Overall comparison. (b) Subgroup comparisons by type of
arthroplasties. Group 1: PKR, primary knee replacement; group 2: PHR, primary hip replacement; group 3: RKR, revision knee replacement; group 4: RHR, revision hip replacement.
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(n ¼ 187) were also analyzed to observe the differences in OKS and
OHS between the short- and the mid-term follow-up (Fig. 4). The
improvement according to OKS and OHS between the short-term
and mid-term scores was statistically signiﬁcant for primary
replacements (P < .001) but not for revision replacements (Table 2).
Actually, for RKR, there was a nonsigniﬁcant decrease in OKS
between short and mid term.
Discussion
Results are consistent with short-term HRQoL improvement
after hip and knee arthroplasties. This improvement continues
more gradually into the mid term, demonstrating that most
important changes are observed during the ﬁrst few months. Both,
primary and revision arthroplasties showed similar scores in the
short term, but in the mid term, no additional signiﬁcant
improvements were observed for the revision groups. This can be
related to the smaller numbers for the mid-term follow-up for
revision replacements. Scores, such as the Oxford knee and hip
scores, may have a ceiling effect in the mid and long term, as is
probably shown in the scores from the revision arthroplasties
[1,22,23].
These results conﬁrm that most important changes in HRQoL
occur during early stages after the surgery for all arthroplasty
groups; moreover we demonstrated that this improvement could
be evidenced as early as in the ﬁrst few months after the surgery.
Other studies have shown improvement at 6 months after surgery
[26,27], consistent with our results, but to our knowledge, this is
the ﬁrst study to show improvement before the 6-month period.
This new fact helps to understand the natural history of these
procedures and what expectations may be offered to the patient in
the short term and mid term. The group of patients with the most
improvement, for both the short term and mid term, was the PHR
group. This is especially important when compared to the PKR
group, where improvement is not as good, consistent with previous
studies [1].
Patient perceptions and self-reported HRQoL scores are critical
in PROMs assessments. It has been demonstrated that higher
patient baseline expectations for total joint replacement are related
to better HRQoL outcomes. In conjunction with the HRQoL
assessment, the clinician could also measure other PROM outcomes
with the hope of achieving better results in the short and mid
term [28,29].Please cite this article in press as: J.P. Martinez-Cano, et al., Prospective q
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has further concerns. Interpreting changes in HRQoL remains
challenging. The clinician must correctly correlate the patient’s
environment and perspective, clinical factors, and social/economic
burden with PROMs in order to fully interpret the result in each
case [10]. Despite the difﬁculties, comparing the change in the
median for a group of patients gives a general idea of what is
happening with patients, which is valuable. In the case of this
study, a signiﬁcant trend toward improvement was found.
As discussed, arthroplasties have good results, in terms of
improvements on the HRQoL, in the short andmid term. In the case
of this cohort, we still have to wait for longer follow-up results in
order to evaluate the long-term results, which we expect may show
that the improvement is maintained over time, as has been shown
in other studies [30]. Long-term follow-up, in our study, could
conﬁrm the duration of the effect of this improvement in HRQoL
and would allow an exploration of a possible ceiling effect.
The limitations of this study include the exclusion from the
analysis of participants whose prosthesis failed and those patients
who required a revision or a limb amputation. These exclusion
criteria led to the exclusion of 2 patients for the short-term follow-
up and 4 for the mid-term follow-up. Follow-up was above 75% in
the short term but it decreased to 67% in the mid term; this could
introduce bias in the overall results. Patients could not attend for
their follow-up for various reasons: because, for example, they felt
well and decided not to come back as they felt they did not need
any follow-up or, conversely, perhaps because they felt so bad that
they decided to change their doctor. There are, additionally, 2 well-
known problems that commonly arise in Colombia that can affect
follow-up. The ﬁrst problem is administrative changes at the
patient’s insurance company, which can mean that the patient is
later assigned to a different health facility; and the second is that
patients frequently change their cell phone numbers. It is very
challenging, because of these problems, to improve the follow-up
percentages, as discussed in other publications [10]. In the
current study, we actually have good follow-up percentages; other
studies using PROMs have, for example, presented similar problems
with follow-up at 6 months of 59% and at 2 years of 37% [25].
Conclusions
Signiﬁcant improvement of patients HRQoL is achieved
following either a primary or revision hip/knee arthroplasty. Most
important HRQoL enhancement is observed during earlier stagesuality of life assessment after hip and knee arthroplasty: short- and
/10.1016/j.artd.2016.09.008
J.P. Martinez-Cano et al. / Arthroplasty Today xxx (2016) 1e66(4-5 months) and continues during the mid term (12-14 months).
HRQoL can be assessed earlier than 6 months after the surgery
demonstrating signiﬁcant changes. Among studied arthroplasties,
PHR has the highest impact in HRQoL.
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